IRCT20081027001411N4已完成2 期
Study of Tocilizumab effect on treatment and clinical symptoms and laboratory signs of Iranian COVID-19 patients: a ?crinical trial study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •COVID-19 patients confirmed by positive PCR ?test for SARS-CoV-19
- •or confirmed by abnormal CT scan finding (bilateral, sub pleural, peripheral ground glass ?opacities),
- •With blood oxygen saturation <93%, or respiratory rate> 24
- •high CRP rate,
- •lymphopenia < 1100
- •not responding to standard COVID-19 treatment.
排除标准
- •A history of malignancies, positive pro-calcitonin and active infection (Including latent or active TB infection)
- •A history of taking immunosuppressive drugs and corticosteroids
研究者
相似试验
招募中
3 期
Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patientsIRCT20200510047383N1Arak University of Medical Sciences100
招募中
3 期
Evaluation of The effect of tocilizumab on patients with severe Covid 19IRCT20210408050899N1Ahvaz University of Medical Sciences15
已完成
不适用
A Single-arm, Open-label Study of the Safety and Reduction of Signs and Symptoms During Treatment With Tocilizumab in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis-M05M05PER-129-08PRODUCTOS ROCHE Q.F.S.A.,20
已完成
2 期
A comparative study of the effects of Tocilizumab?, interferon-gamma and vitamin C on the recovery of critically ill Covid-19 patients and cytokine stormCovid-19.Covid-19 diseaseU07.1IRCT20200525047570N1Tabriz University of Medical Sciences60
已完成
不适用
Clinical trial of efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000020389Kanazawa University Hospital, Department of dermatology5